CN101249184B - Medicine for treating osteoproliferation as well as its preparation method - Google Patents
Medicine for treating osteoproliferation as well as its preparation method Download PDFInfo
- Publication number
- CN101249184B CN101249184B CN2008100695202A CN200810069520A CN101249184B CN 101249184 B CN101249184 B CN 101249184B CN 2008100695202 A CN2008100695202 A CN 2008100695202A CN 200810069520 A CN200810069520 A CN 200810069520A CN 101249184 B CN101249184 B CN 101249184B
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- hyperosteogeny
- rhizoma
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a medicine for treating hyperosteogeny and a preparation method. The invention is characterized in that the medicine is made by mixing raw ingredients with seed fat, wherein, the medicine has the raw ingredients by weight parts as follows: homalomena rhizome is 1 to 3, everflowering rose is 1 to 5, coralbean bark is 1 to 5, gentian is 1 to 2, herba lycopodti is 1 to 5, borneol is 0.1 to 1, rhizoma drynariae is 1 to 5, rhizoma ligustici wallichii is 1 to 3, radix bupleuri is 1 to 4, ground beetles are 1 to 3, radix paeoniae rubra is 1 to 3, roots of Spinyleaf Pricklyash is 1 to 3, and tibetan hellebore is 1 to 2. The medicine is pure TCM preparations, has no toxic side effects and low cost, cures the hyperosteogeny, and has stable curative effect and extremely low relapse rate.
Description
Technical field
The present invention relates to a kind of medicine that is used for the treatment of hyperosteogeny and preparation method thereof.
Background technology
The types of drugs that is used for the treatment of hyperosteogeny at present is various, but most curative effect of medication is all unstable, can only alleviate pain for the moment, and relapse rate is higher; And the drug price costliness that has, the poisonous side effect of medicine that has is bigger.
Summary of the invention
Purpose of the present invention just is to provide a kind of stable curative effect, the medicine that is used for the treatment of hyperosteogeny that toxic and side effects is little.
Another object of the present invention provides the preparation method of this medicine.
The object of the present invention is achieved like this: a kind of medicine that is used for the treatment of hyperosteogeny is characterized in that it is to be made by the raw material of following weight portion: Rhizoma Homalomenae 1～3, Flos Rosae Chinensis 1～5, Cortex erythrinae 1～5, Radix Gentianae 1～2, Herba Lycopodii 1～5, Borneolum Syntheticum 0.1～1, Rhizoma Drynariae 1～5, Rhizoma Chuanxiong 1～3, Radix Bupleuri 1～4, Eupolyphaga seu steleophaga 1～3, Radix Paeoniae Rubra 1～3, Radix Zanthoxyli Spinifolii 1～3 and Radix Chimonanthi praecocis 1～2.
The medicine of above-mentioned treatment hyperosteogeny, wherein the consumption of each crude drug is preferably in weight portion: Rhizoma Homalomenae 1, Flos Rosae Chinensis 1, Cortex erythrinae 1, Radix Gentianae 1, Herba Lycopodii 1, Borneolum Syntheticum 0.5, Rhizoma Drynariae 1, Rhizoma Chuanxiong 1, Radix Bupleuri 1, Eupolyphaga seu steleophaga 1, Radix Paeoniae Rubra 1, Radix Zanthoxyli Spinifolii 1 and Radix Chimonanthi praecocis 1.
The medicine of above-mentioned treatment hyperosteogeny is preferably unguentum.
Another object of the present invention is that the preparation method of the medicine of above-mentioned treatment hyperosteogeny is that all components in the said ratio is pulverized, and is modulated into paste with vegetable oil then.
In the above-mentioned preparation method, all components grinding particle size is 100～120 orders, and above-mentioned vegetable oil is selected salad oil for use, preferably 50～80 ℃ of refining temperatures.
The usage and the consumption of medicine of the present invention are as follows: get above-mentioned gained plaster, pinch flatly, smooth on cloth with hands, gently overlay in the affected part.The concrete size of ointment area depends on position, affected part area (ointment thickness does not affect the treatment).10 days (have a bath during the medication and can take down this medicine, etc. continue after the xerosis cutis stick) used in the every subsides of this medicine, and ten to paste be a course of treatment.
Beneficial effect of the present invention is: (1) medicine of the present invention is according to the Chinese medical theory prescription, and strengthening the body resistance is arranged, dispelling cold and dehumidification, and the effect of acupuncture-stimulating blood stasis dispersing, thus can effectively treat hyperosteogeny.The Rhizoma Homalomenae of wherein selecting for use, Flos Rosae Chinensis, Cortex erythrinae, Radix Gentianae, Herba Lycopodii works the effect of dispeling the wind; Rhizoma Drynariae, Rhizoma Chuanxiong, Radix Bupleuri, Eupolyphaga seu steleophaga, Radix Paeoniae Rubra can blood circulation promoting and blood stasis dispelling, hard masses softening and resolving; Radix Zanthoxyli Spinifolii, Radix Chimonanthi praecocis, Borneolum Syntheticum are symbol side.(2) ointment of the present invention is used for clinical treatment 830 routine patients, wherein the age reckling is 15 years old, and the oldest person is 88 years old, and all more than 3 years, the course of disease reaches 36 years most to the course of disease; The diagnoses and treatment standard is according to " People's Republic of China's Chinese medicine industry standard disease of tcm diagnosis criterion of therapeutical effect " ZY/T001.1-001.9-94 of State Administration of Traditional Chinese Medicine's issue; Therapeutic Method is not regardless of type for to meeting the disease of hyperosteogeny class by stages, and unified use plaster of the present invention is attached to diseased region under doctor's guidance, and every subsides were used ten days, and ten subsides are a course of treatment.According to further consultation record, return visit record statistics curative effect; Clinical therapeutic efficacy of the present invention shows: treatment hyperosteogeny of cervical vertebra 392 examples, and effective percentage is 98.99%; Treatment intervertebral disk hernia 102 examples, effective percentage is 98%; Sciatica 159 examples that treatment causes because of hyperosteogeny, effective percentage is 97%; Because of body part pain 187 examples that hyperosteogeny causes, effective percentage is 88%.(3) medicine of the present invention is a pure Chinese medicinal preparation, and is used for external application, and is safe in utilization, and clinical for many years use proves that this medicine has no side effect, not chafe.(4) medicine material of the present invention is common medicine, low price, and preparation method is simple, and with low cost.(5) inventor observes according to clinical use for many years, generally speaking, uses this medicine 2～3 to paste obviously alleviating pain symptom, continues to use can thoroughly cure hyperosteogeny to year half a year, and relapse rate is extremely low, and curative effect can be stablized more than 3～5 years.
The specific embodiment
Mode below by embodiment further specifies the present invention, does not therefore limit the present invention among the described scope of embodiments.
Embodiment 1:
A kind of medicine that is used for the treatment of hyperosteogeny, wherein the consumption of each crude drug is counted with weight portion: Rhizoma Homalomenae 1, Flos Rosae Chinensis 1, Cortex erythrinae 1, Radix Gentianae 1, Herba Lycopodii 1, Borneolum Syntheticum 0.5, Rhizoma Drynariae 1, Rhizoma Chuanxiong 1, Radix Bupleuri 1, Eupolyphaga seu steleophaga 1, Radix Paeoniae Rubra 1, Radix Zanthoxyli Spinifolii 1 and Radix Chimonanthi praecocis 1.
Manufacturing method for above mentioned medicine is: it is 100 purpose powder that all components in the said ratio is ground into granularity, is that 60 ℃ salad oil is modulated into paste with temperature then.
Embodiment 2:
Wherein each component raw material proportioning sees Table 1; In the preparation method: all components grinding particle size is 120 orders, and the salad oil temperature is 50 ℃, and all the other are with embodiment 1.
Embodiment 3:
Wherein each component raw material proportioning sees Table 1; In the preparation method: all components grinding particle size is 110 orders, and the salad oil temperature is 70 ℃, and all the other are with embodiment 1.
Embodiment 4:
Wherein each component raw material proportioning sees Table 1; In the preparation method: all components grinding particle size is 120 orders, and the salad oil temperature is 80 ℃, and all the other are with embodiment 1.
Each component raw material proportioning (weight portion) among table 1 embodiment 2～4
| Rhizoma Homalomenae | Flos Rosae Chinensis | Cortex erythrinae | Radix Gentianae | Herba Lycopodii | Borneolum Syntheticum | Rhizoma Drynariae | Rhizoma Chuanxiong | Radix Bupleuri | Eupolyphaga seu steleophaga | Radix Paeoniae Rubra | Radix Zanthoxyli Spinifolii | Radix Chimonanthi praecocis | Salad oil | |
| Embodiment 2 | 3 | 5 | 5 | 2 | 5 | 0.1 | 5 | 3 | 4 | 3 | 3 | 3 | 2 | 8 |
| Embodiment 3 | 2 | 3 | 3 | 1 | 2 | 0.3 | 3 | 2 | 3 | 2 | 2 | 2 | 1 | 5 |
| Embodiment 4 | 1.5 | 2 | 2 | 1.5 | 3 | 1 | 2 | 1 | 1.5 | 1 | 1.5 | 2 | 1.5 | 4 |
Claims (5)
1. a medicine that is used for the treatment of hyperosteogeny is characterized in that it is to be made by the raw material of following weight portion: Rhizoma Homalomenae 1～3, Flos Rosae Chinensis 1～5, Cortex erythrinae 1～5, Radix Gentianae 1～2, Herba Lycopodii 1～5, Borneolum Syntheticum 0.1～1, Rhizoma Drynariae 1～5, Rhizoma Chuanxiong 1～3, Radix Bupleuri 1～4, Eupolyphaga seu steleophaga 1～3, Radix Paeoniae Rubra 1～3, Radix Zanthoxyli Spinifolii 1～3 and Radix Chimonanthi praecocis 1～2.
2. according to the medicine of claim 1, wherein the consumption of each crude drug is counted with weight portion: Rhizoma Homalomenae 1, Flos Rosae Chinensis 1, Cortex erythrinae 1, Radix Gentianae 1, Herba Lycopodii 1, Borneolum Syntheticum 0.5, Rhizoma Drynariae 1, Rhizoma Chuanxiong 1, Radix Bupleuri 1, Eupolyphaga seu steleophaga 1, Radix Paeoniae Rubra 1, Radix Zanthoxyli Spinifolii 1 and Radix Chimonanthi praecocis 1.
3. the medicine of treatment hyperosteogeny according to claim 1 and 2 is characterized in that this medicine is a unguentum.
4. according to the preparation method of the medicine of the described treatment hyperosteogeny of arbitrary claim in the claim 1～3, it is characterized in that all components in the described proportioning is pulverized, be modulated into paste with vegetable oil then.
5. the preparation method of the medicine of treatment hyperosteogeny according to claim 4 is characterized in that described component grinding particle size is 100～120 orders, and described vegetable oil is a salad oil, and refining temperature is 50～80 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100695202A CN101249184B (en) | 2008-03-31 | 2008-03-31 | Medicine for treating osteoproliferation as well as its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100695202A CN101249184B (en) | 2008-03-31 | 2008-03-31 | Medicine for treating osteoproliferation as well as its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101249184A CN101249184A (en) | 2008-08-27 |
| CN101249184B true CN101249184B (en) | 2010-06-16 |
Family
ID=39952894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100695202A Expired - Fee Related CN101249184B (en) | 2008-03-31 | 2008-03-31 | Medicine for treating osteoproliferation as well as its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101249184B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125648B (en) * | 2011-03-09 | 2012-07-04 | 罗建国 | Medicament for treating hyperosteogeny and preparation method thereof |
| CN102920895B (en) * | 2012-11-21 | 2014-04-02 | 车培彩 | Traditional Chinese medicine for treating alveolar hypoventilation syndrome |
| CN103877467B (en) * | 2014-04-09 | 2016-05-18 | 刘自金 | A kind of Chinese medicinal capsule for the treatment of osteoproliferation |
| CN104922481A (en) * | 2015-03-13 | 2015-09-23 | 安庆市凯达生物科技发展有限责任公司 | External traditional Chinese medicine composition for treating neck-shoulder and lumbocrural pain and preparation process thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1444954A (en) * | 2002-03-19 | 2003-10-01 | 郭世维 | Boneset pills |
-
2008
- 2008-03-31 CN CN2008100695202A patent/CN101249184B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1444954A (en) * | 2002-03-19 | 2003-10-01 | 郭世维 | Boneset pills |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101249184A (en) | 2008-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100493594C (en) | Plaster for treating cholecystitis, cholangitis and bile gastritis | |
| CN101366892A (en) | Chinese medicinal composition for treating menorrhalgia | |
| CN101249184B (en) | Medicine for treating osteoproliferation as well as its preparation method | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN101822739A (en) | Medicine for treating burn and preparation method thereof | |
| CN101129872A (en) | Phellodendron bark-coix seed erysipelas powder | |
| CN1090495C (en) | Jieyinjing washing liquid for cleaning pudendum | |
| CN103977318A (en) | Liniment of traditional Chinese medicine composition for treating skin disease and preparation method thereof | |
| CN101721537A (en) | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis | |
| CN100386106C (en) | Medicine for treating acne and its preparation | |
| CN1244353C (en) | Medicine for curing acne and its preparation method | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN100333738C (en) | Chinese medicinal ointment for treating bone diseases | |
| CN1883642A (en) | Medicine for treating mammary glands hyperplasia | |
| CN103041192B (en) | Bedsore paste | |
| CN1167455C (en) | Medicine for treating acne and its preparing process | |
| CN102698202B (en) | Chinese medicinal composition for treating gall-stone and preparation method and application of Chinese medicinal composition | |
| CN102357147B (en) | Chinese medicine composite tincture capable of diminishing inflammation, relieving pain and preventing viruses and preparation method thereof | |
| CN101073657A (en) | 'Yu Chuang Dan' Chinese-medicinal preparation for treating recurrent oral exulceratio | |
| CN1814218A (en) | Hormone external-dressing agent for treating dermatitis | |
| CN110302269A (en) | A kind of warming and activating meridian foot-soaking liquid | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN1257732C (en) | Medicine for treating mastosis and preparation process thereof | |
| CN105582223A (en) | External traditional Chinese medicine for treating acute and chronic traumatic injuries | |
| CN105381177A (en) | External use traditional Chinese medicine for treating sweet stains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100616 Termination date: 20150331 |
|
| EXPY | Termination of patent right or utility model |